Biologics Opportunities in  Devens, MA

Work with state-of-the-art biologics at our Biologics Center of Excellence.
Biologics Opportunities in Devens, Massachusetts

Biologics are increasingly important in the treatment of serious diseases and are a growing part of the Bristol-Myers Squibb portfolio of products and R&D pipeline. Bringing together biologics development and clinical and commercial manufacturing on one campus (Devens, Massachusetts) can help accelerate the development of these innovative medicines for patients worldwide.


Bristol-Myers Squibb biologics facility in Devens, Massachusetts
Learn More

Bristol-Myers Squibb has made expanding its biologics manufacturing capacity and development capabilities a strategic priority. With a $280 million site expansion in 2016, Bristol-Myers Squibb has now invested more than $1 billion in its Devens, Massachusetts site.  The recent project added two new buildings with a combined 200,000 square feet to the Devens campus: 

  • a Biologics Development Building for designing processes for the early production of investigational medicines, and
  • a Clinical Manufacturing Building where investigational medicines will be produced to support clinical trials.

Both are new capabilities for Devens, a site that had previously focused solely on large-scale, bulk biologics manufacturing.

The expansion brings new capabilities, combining biologics process development, clinical manufacturing and commercial manufacturing in one facility to help accelerate the speed at which potential new therapies progress from development to commercial manufacturing.

Make a difference in our Biologics Center of Excellence 

  • Commercial and Clinical Biologics Manufacturing
  • Process Development
  • Manufacturing Science and Technology

Collaboration is further enhanced by the interior design, which features flexible, open floor plans, and a variety of quiet and collaborative areas – all reflecting a broader company initiative to provide employees with more efficient workspaces that enable collaboration, creativity and innovation.

The two buildings also reflect the company’s commitment to sustainability. The new Biologics Development Building has received Leadership in Energy and Environmental Design (LEED®) Silver certification for energy and environmental design, and the Clinical Manufacturing Building is also targeted for LEED Silver certification. Sustainable features included in the new buildings include an abundance of natural light, a green roof, high efficiency lighting and water systems, water-efficient landscaping and wood products from sustainable sources.

Our biologics facility in Devens, Massachusetts

Inside the labs at our Devens facility
Employees work on potential biologics medicines inside the Biologics Development Building.

Manufacturing at Devens
Employees work in the Clinical Manufacturing Building. In Clinical Manufacturing, investigational medicines are produced in relatively small quantities for use in clinical trials.

Collaborative Work Spaces
Employees work in new collaborative workspaces. 

Bristol-Myers Squibb is an equal opportunity employer.  Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.  For our EEO Policy Statement, please click here.  If you’d like more information on your EEO rights under the law, please click here.  EEO is the LAW and Supplemental Information.